CO4940459A1 - Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion - Google Patents

Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion

Info

Publication number
CO4940459A1
CO4940459A1 CO96063581A CO96063581A CO4940459A1 CO 4940459 A1 CO4940459 A1 CO 4940459A1 CO 96063581 A CO96063581 A CO 96063581A CO 96063581 A CO96063581 A CO 96063581A CO 4940459 A1 CO4940459 A1 CO 4940459A1
Authority
CO
Colombia
Prior art keywords
treatment
gastrointestial
disorders
manufacture
composition
Prior art date
Application number
CO96063581A
Other languages
English (en)
Inventor
Jamesina Anne Fitzgerald
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO4940459A1 publication Critical patent/CO4940459A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/245—Bismuth; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se relaciona con el uso de desde 50miligramos hasta 5.000 miligramos de bismuto por día por desde 1 hasta 56 días y desde 100 hasta 10.000 miligramos de uno o más de cada antimicrobial por día por desde 1 hasta 28 días para la elaboración de una composición para el tratamiento de un desorden gastrointestinal causado o mediado por uno o más organismos seleccionados del grupo consistente de algas, cianobacterias y combinaciones de ellas. También se relaciona con una composición para el tratamiento de un desorden gastrointestinal causado o mediado por una o más algas intestinales, cianobaterianas o mezclas de ellas que comprende un compuesto de bismuto y uno o más compuestos antimicrobiales, en donde el compuesto de bismuto y el compuesto antimicrobial están presentes en unidades de dosificación separada.
CO96063581A 1995-12-07 1996-12-04 Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion CO4940459A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/569,029 US5744168A (en) 1995-12-07 1995-12-07 Methods and compositions for the prevention and treatment of gastrointestinal disorders

Publications (1)

Publication Number Publication Date
CO4940459A1 true CO4940459A1 (es) 2000-07-24

Family

ID=24273803

Family Applications (1)

Application Number Title Priority Date Filing Date
CO96063581A CO4940459A1 (es) 1995-12-07 1996-12-04 Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion

Country Status (17)

Country Link
US (1) US5744168A (es)
EP (1) EP0865284B1 (es)
AT (1) ATE231726T1 (es)
BR (1) BR9612123A (es)
CA (1) CA2239423C (es)
CO (1) CO4940459A1 (es)
DE (1) DE69626036T2 (es)
DK (1) DK0865284T3 (es)
ES (1) ES2191776T3 (es)
IL (1) IL124792A (es)
MX (1) MX9804577A (es)
MY (1) MY113635A (es)
NO (1) NO319386B1 (es)
PT (1) PT865284E (es)
TR (1) TR199801024T2 (es)
TW (1) TW445143B (es)
WO (1) WO1997020565A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
JP2005504756A (ja) * 2001-08-08 2005-02-17 マリア・アントニア・ガルシア−オルメド・ドミンゲス 注射可能な泡製剤および新規な医薬的適用
FR2962684B1 (fr) 2010-07-13 2012-08-24 Oberthur Technologies Procede de realisation d'un motif sur un support avec une encre de securite

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR962163A (es) * 1950-06-02
US4049817A (en) * 1972-08-14 1977-09-20 Sandoz Ltd. Synergistic compositions
US4514421A (en) * 1979-08-30 1985-04-30 Herschler R J Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
US5256684A (en) * 1985-06-13 1993-10-26 The Procter & Gamble Company Methods and compositions for the treatment of gastrointestinal disorders
ATE318144T1 (de) * 1985-06-13 2006-03-15 Barry James Marshall Pharmazeutische zusammensetzung zur behandlung gastrointestinaler beschwerden, die wismut und ein antimikrobielles mittel enthält
JPS63174926A (ja) * 1987-01-09 1988-07-19 Nitto Kasei Kk 家禽用抗コクシジウム剤
IL85472A (en) * 1987-03-09 1991-06-30 Procter & Gamble Pharmaceutical compositions for treating gastrointestinal disorders
EP0439453B1 (en) * 1987-10-12 1994-01-19 Exomed Australia Pty. Ltd. (ACN 051 976 446) Improved method for treatment of gastrointestinal disorders
EP0375068A1 (en) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Combining bismuth compounds and tetracyclines
US5221664A (en) * 1990-04-23 1993-06-22 Magainin Pharmaaceuticals Inc. Composition and treatment with biologically active peptides and toxic cations
WO1992001457A1 (en) * 1990-07-20 1992-02-06 Slagel, David Products and processes for the treatment of the alimentary canal
ATE184198T1 (de) * 1993-05-11 1999-09-15 Spirig Ag Festes bismut- und amoxycillinhaltiges arzneipräparat und seine verwendung
AUPM596894A0 (en) * 1994-05-30 1994-06-23 Hybrid Scientific Pty Ltd Composition for treating gastrointestinal disorders - a combination of bismuth salts plus lactobacillus or bifidobacteria species bacteria for treating gastrointestinal disorders

Also Published As

Publication number Publication date
WO1997020565A1 (en) 1997-06-12
NO982635D0 (no) 1998-06-08
ATE231726T1 (de) 2003-02-15
DE69626036D1 (de) 2003-03-06
DE69626036T2 (de) 2004-01-22
ES2191776T3 (es) 2003-09-16
CA2239423A1 (en) 1997-06-12
EP0865284B1 (en) 2003-01-29
CA2239423C (en) 2003-04-01
NO982635L (no) 1998-08-04
US5744168A (en) 1998-04-28
MX9804577A (es) 1998-10-31
IL124792A (en) 2004-01-04
NO319386B1 (no) 2005-08-08
DK0865284T3 (da) 2003-05-19
IL124792A0 (en) 1999-01-26
PT865284E (pt) 2003-06-30
MY113635A (en) 2002-04-30
BR9612123A (pt) 1999-02-17
EP0865284A1 (en) 1998-09-23
TR199801024T2 (xx) 1998-09-21
TW445143B (en) 2001-07-11

Similar Documents

Publication Publication Date Title
CO4940459A1 (es) Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion
CO4761072A1 (es) Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion
CO4790098A1 (es) Composicion para el tratamiento de trastornos gastrointes- tinales y metodo para su fabricacion
CO4761071A1 (es) Composicion para el tratamiento de trastornos gastrointesti- nales y metodo para su fabricacion